Business
FDA Advisers Back Moderna’s Covid-19 Vaccine
Dec.17 — Moderna Inc.’s Covid-19 vaccine wins backing from a panel of experts who advise U.S. regulators. Food and Drug Administration advisers voted 20 to 0, with one abstention, on Thursday that the benefits of the vaccine outweigh any risk. Robert Langreth reports on “Bloomberg Daybreak: Australia.”
source